share_log

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday

Benzinga Real-time News ·  Sep 23, 2022 03:43

Gainers

  • Spero Therapeutics, Inc.(NASDAQ:SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties.
  • Avenue Therapeutics, Inc.(NASDAQ:ATXI) gained 105.9% to close at $0.44 after the company received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol. The company also announced the effectiveness of its 1-for-15 reverse split on Sept. 23.
  • Panbela Therapeutics, Inc.(NASDAQ:PBLA) gained 46.4% to close at $0.3550.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment